New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation (Q38057376)

27 August 2017

title

New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation (English)

1 reference

27 August 2017

Eleni Kotsiou

1 reference

27 August 2017

Jeff K Davies

series ordinal

1 reference

27 August 2017

language of work or name

English

0 references

publication date

5 November 2012

1 reference

British Journal of Haematology

27 August 2017

published in

1 reference

27 August 2017

volume

160

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

133-145

1 reference

Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.

27 August 2017

cites work

1 reference

Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells

21 January 2018

1 reference

Regulatory T cells: stability revisited

21 January 2018

1 reference

Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs

21 January 2018

1 reference

Mechanisms of suppression by suppressor T cells

21 January 2018

1 reference

Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity

21 January 2018

1 reference

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

21 January 2018

1 reference

Enhancing graft-versus-leukemia after transplant: the rise of anti-cancer vaccines

21 January 2018

1 reference

Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues

21 January 2018

1 reference

Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).

21 January 2018

1 reference

Genetic engineering of T cells for the immunotherapy of haematological malignancies.

21 January 2018

1 reference

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease

21 January 2018

1 reference

Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells

21 January 2018

1 reference

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

21 January 2018

1 reference

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

21 January 2018

1 reference

Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease

21 January 2018

1 reference

Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses

21 January 2018

1 reference

Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation

21 January 2018

1 reference

Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.

21 January 2018

1 reference

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease

21 January 2018

1 reference

Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation

21 January 2018

1 reference

Pathophysiology of graft-versus-host disease

21 January 2018

1 reference

The immunopathophysiology of acute graft-versus-host-disease

21 January 2018

1 reference

Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.

21 January 2018

1 reference

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

21 January 2018

1 reference

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

21 January 2018

1 reference

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL

21 January 2018

1 reference

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

21 January 2018

1 reference

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity

21 January 2018

1 reference

Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease

21 January 2018

1 reference

Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes

21 January 2018

1 reference

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

21 January 2018

1 reference

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease

21 January 2018

1 reference

Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.

21 January 2018

1 reference

Organ-derived dendritic cells have differential effects on alloreactive T cells.

21 January 2018

1 reference

Interleukin-2 and regulatory T cells in graft-versus-host disease

21 January 2018

1 reference

P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects

21 January 2018

1 reference

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells

21 January 2018

1 reference

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

21 January 2018

1 reference

Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors.

21 January 2018

1 reference

Reduced-intensity conditioning allogeneic stem cell transplantation for older adults: is it the standard of care?

21 January 2018

1 reference

Retinoic acid‐induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation

21 January 2018

1 reference

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

21 January 2018

1 reference

Association of Foxp3 regulatory gene expression with graft-versus-host disease

21 January 2018

1 reference

Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow

21 January 2018

1 reference

Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease

21 January 2018

1 reference

In vivo imaging of graft-versus-host-disease in mice

21 January 2018

1 reference

Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors

21 January 2018

1 reference

Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy

21 January 2018

1 reference

LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

21 January 2018

1 reference

Prophylaxis regimens for GVHD: systematic review and meta-analysis

21 January 2018

1 reference

CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen

21 January 2018

1 reference

Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease

21 January 2018

1 reference

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

21 January 2018

1 reference

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

21 January 2018

1 reference

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

21 January 2018

1 reference

Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease

21 January 2018

1 reference

Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells

21 January 2018

1 reference

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.

21 January 2018

1 reference

CCR2 is required for CD8-induced graft-versus-host disease.

21 January 2018

1 reference

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

21 January 2018

1 reference

Human regulatory T cells in allogeneic stem cell transplantation.

21 January 2018

1 reference

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

21 January 2018

1 reference

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

21 January 2018

1 reference

Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine

21 January 2018

1 reference

Regulatory T Cells: Customizing for the Clinic

21 January 2018

1 reference

Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions

21 January 2018

1 reference

The structural basis of T-cell allorecognition

21 January 2018

1 reference

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

21 January 2018

1 reference

Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

21 January 2018

1 reference

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

21 January 2018

1 reference

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12115

1 reference

27 August 2017

1 reference